Phase II study of pirarubicin in metastatic breast cancer.
Kleeberg UR, Reichel L, Wander HE, Beyer JH, Essers U, Fiebig HH, Salewski E, Greifenberg B, Edler L.
Kleeberg UR, et al. Among authors: greifenberg b.
Onkologie. 1990 Jun;13(3):175-9. doi: 10.1159/000216753.
Onkologie. 1990.
PMID: 2204003
Clinical Trial.